18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR2400079712
正在进行
/
/
/
2024-01-10
/
/
Mitigating loneliness
Mitigating loneliness of older adults through cognitive behavioral approach and peer and family support: A randomized controlled trial
Mitigating loneliness of older adults through cognitive behavioral approach and peer and family support: A randomized controlled trial
To evaluate the efficacy of an intervention based on the cognitive behavioral therapy and peer and family support in reducing loneliness, depression, anxiety, and improving social support, life satisfaction, social cognition and quality of life among older adults in Hong Kong
随机平行对照
其它
Randomization will be performed by the research assistant who will not be involved in participation recruitment and assessment. Block randomization (size =6) will be used, and participants will be randomly allocated to either intervention or control group, using a computer-generated random numbers table. Allocation will be concealed by serial-numbered opaque sealed envelopes (SNOSE). Such a masking procedure can avoid any bias in completing the baseline questionnaire, and the design follows recommendations of CONSORT Statements to guide randomized controlled studies.
None
Health and Medical Research Fund, Food and Health Bureau
/
127
/
2023-10-01
2025-12-31
/
1) aged 60 to 75; 2) being able to speak Chinese and understand Chinese; 3) HK residents (current holders of a HK permanent identity card); 4) having an active internet connection; 5) possess at least one device (e.g. smartphone) that has an online social networking platform (e.g. Whatsapp); 6) have a minimal ability to operate the device (i.e., turning it on and off or sending messages); 7) with cognitive ability to complete a telephone interview.;
登录查看1) currently receiving psychiatric care; and 2) have taken part in any psychological interventions in the past six months.;
登录查看The Chinese Univesity of Hong Kong
/
药渡2024-10-26
国风红源达2024-10-26
凯莱英药闻2024-10-26
药明康德2024-10-26
药明康德2024-10-26
药明康德2024-10-26
研发客2024-10-26
Insight数据库2024-10-25
中国上海自贸试验区2024-10-25
癌度2024-10-25